Valeant Pharma (VRX) Completes Amendment to Credit Agreement
Tweet Send to a Friend
Valeant Pharma (NYSE: VRX) disclosed in an SEC filing:Credit Agreement AmendmentOn March 28, 2017, Valeant Pharmaceuticals International, Inc. (the “Company”) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE